natgillin/translations-raw huggingface dataset:
Uncommon (in more than 1 in 1000 patients but less than 1 in 100 patients): • serious infections (including tuberculosis, histoplasmosis and sepsis [blood poisoning]), joint infection; • skin infections, skin warts, superficial fungal infections; • anaemia, low white blood cell and platelet counts, lymphopaenia (low immune cell counts); • swelling of the lymph nodes; • systemic lupus erythematosus; • allergic reactions (including seasonal and medicines allergy; • increased lipid and uric acid values, appetite disorders; • anxiety, depression, feeling sleepy and difficulty sleeping, shaking; • taste disturbances; • vision disturbances, eye inflammation or infection; • ear discomfort; • sensation of heart beating irregularly, high blood pressure, flushng; • asthma, shortness of breath, hoarseness; • abdominal symptoms (such as vomiting, constipation), rectal bleeding; • skin disorders (such as psoriasis, eczema or infections), itchy rash, slow wound healing, bruising, hair loss; • muscle weakness;
Občasno (pri več kot 1 od 1000 bolnikov, vendar manj kot pri 1 od 100 bolnikov): • resne okužbe (vključno s tuberkulozo, histoplazmozo in sepso [zastrupitev krvi]), okužba sklepa; • okužbe kože, bradavice na koži, povrhnje glivične okužbe; • anemija, zmanjšanje števila belih krvnih celic in krvnih ploščic, limfopenija (zmanjšano število imunskih celic v krvi); • oteklost bezgavk; • sistemski lupus eritematosus; • alergijske reakcije (vključno s sezonskimi alergijami in alergijami na zdravila); • zvišani lipidi in sečna kislina, motnje apetita; • tesnobnost, depresija, zaspanost in težave s spanjem, tresenje; • motnje okusa; • motnje vida, vnetje ali okužba očesa; • neprijeten občutek v ušesu; • občutek neenakomernega bitja srca, visok krvni pritisk, zardevanje; • astma, hitra zadihanost, hripavost; • trebušni simptomi (npr. bruhanje, zaprtje), krvavitve v danko; • bolezni kože (npr. luskavica, ekcem ali okužbe), srbeč izpuščaj, počasno celjenje ran, podplutbe, izpadanje las; • mišična šibkost; • motnje na sečilih (npr. kri v urinu, pogostejše uriniranje); • močnejše menstruacijske krvavitve;
153 • urinary disturbances (such as blood in urine, increased urinary frequency); • increased menstrual bleeding; • flu-like symptoms, chest pain, swelling of the feet; • accidental injury, impaired healing.
153 • simptomi podobni gripi, bolečine v prsih, otekanje stopal; • naključna poškodba, slabše celjenje.
HOW TO STORE HUMIRA
SHRANJEVANJE ZDRAVILA HUMIRA
Do not use the Humira vial after the expiry date stated on the label/ blister/ carton after EXP:
Zdravila Humira ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki/ pretisnem omotu/ škatli za “ Uporabno do: ”.
Keep the vial in the outer carton
Vialo shranjujte v zunanji ovojnini.
What Humira contains
Kaj vsebuje zdravilo Humira
This medicinal product contains less than 1 mmol of sodium (23 mg) per 0.8 ml dose, i. e. essentially ‘ sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) v 0, 8 ml odmerku, kar pomeni, da je praktično ‘ brez natrija ’.
Humira 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg adalimumab dissolved in 0.8 ml solution.
Humira 40 mg raztopina za injiciranje v vialah je na voljo kot sterilna raztopina 40 mg adalimumaba, raztopljenega v 0, 8 ml raztopine.
The Humira vial is a glass vial containing a solution of adalimumab.
Viala s Humiro je steklena viala, ki vsebuje raztopino adalimumaba.
Humira is also available as a pre-filled syringe or a pre-filled pen.
Humira je na voljo tudi kot napolnjena injekcijska brizga in napolnjen injekcijski peresnik.
Abbott Biotechnology Deutschland GmbH Max-Planck-Ring 2 D – 65205 Wiesbaden Germany
Abbott Biotechnology Deutschland GmBH Max- Planck- Ring 2 D- 65205 Wiesbaden Nemčija
155 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
157 PACKAGE LEAFLET:
157 NAVODILO ZA UPORABO
158 Polyarticular juvenile idiopathic arthritis is an inflammatory disease, affecting one or more joints, with diagnosis typically occurring in children under the age of 16 years.
158 zdravila, npr. metotreksat.
Psoriasis is an inflammatory disease of the skin. If you have moderate to severe plaque psoriasis, you will first be given other medicines or e. g. phototherapy If you do not respond well enough to these treatments, you will be given Humira to reduce the signs and symptoms of your psoriasis.
Če se na takšno zdravljenje ne boste odzvali dovolj, boste za zmanjšanje znakov in simptomov psoriaze dobili zdravilo Humira.
• If you are allergic (hypersensitive) to adalimumab or any of the other ingredients of Humira.
• če ste alergični na (preobčutljivi za) za adalimumab ali katerokoli sestavino zdravila Humira.
If you are unsure, please contact your doctor.
• Če imate kakšno okužbo, vključno z dolgotrajno ali omejeno okužbo (npr. razjedo na nogi), se pred uporabo Humire posvetujte s svojim zdravnikom.
• You might get infections more easily while you are receiving Humira treatment.
Če niste gotovi, se posvetujte s svojim zdravnikom.
159 bacteria, or other opportunistic infections and sepsis that may, in rare cases, be life-threatening.
159 • Med zdravljenjem s Humiro se lahko poveča dovzetnost za okužbe.
It is important to tell your doctor if you get symptoms such as fever, wounds, feeling tired or dental problems. Your doctor may recommend temporary discontinuation of Humira.
Vaš zdravnik bo morda priporočil začasno prenehanje uporabe zdravila Humira.
If you develop new or worsening symptoms of heart failure (e. g. shortness of breath, or swelling of your feet), you must contact your doctor immediately.
Če se simptomi srčnega popuščanja (npr. težko dihanje ali otekanje nog) pojavijo na novo ali se poslabšajo, se morate takoj obrniti na svojega zdravnika.
Your doctor will decide if you should receive Humira.
On se bo odločil, ali lahko dobivate Humiro.
People with more serious rheumatoid arthritis that have had the disease for a long time may have a higher than average risk of getting lymphoma, which isa kind of cancer that affects the lymph system.
Pri bolnikih z resnejšim revmatoidnim artritisom, ki imajo bolezen že dolgo, obstaja povečana verjetnost, da zbolijo za limfomom, to je rakom limfatičnega sistema.
On rare occasions, a specific and severe type of lymphoma has been observed in patients taking Humira.
V redkih primerih so pri bolnikih, ki dobivajo Humiro, opazili specifično in resno obliko limfoma.
160 blocker.
160 opazili zelo redke primere nemelanomskega kožnega raka.
In cases where a more rapid response is required your doctor may prescribe a dose of 160 mg at Week 0 (as 4 injections in one day or 2 injections per day for two consecutive days), 80 mg (2 injections) at Week 2, and thereafter as 40 mg (1 injection) every other week.
161 160 mg 0. teden (v 4 injekcijah na en dan ali v 2 injekcijah dva dni zapored), 80 mg (2 injekciji) 2. teden in potem 40 mg (1 injekcija) vsak drugi teden.
The usual dose for adults with psoriasis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose. You should continue to inject Humira for as long as your doctor has told you.
Humiro je treba injicirati toliko časa, kolikor vam je naročil zdravnik.
161 In rheumatoid arthritis, methotrexate is continued while using Humira.
Pri revmatoidnem artritisu se uporaba metotreksata med uporabo Humire nadaljuje.
If you have rheumatoid arthritis and you do not receive methotrexate with your Humira therapy, your doctor may decide to give 40 mg adalimumab every week.
Če imate ravmatoidni artritis in hkrati s Humiro ne dobivate metotreksata, vam bo zdravnik morda predpisal 40 mg adalimumaba vsak teden.
• Wash your hands thoroughly • Set up the following items on a clean surface
• Dobro si umijte roke. • Na čisto površino pripravite naslednje:
One pre-filled syringe of Humira for injection One alcohol pad
eno napolnjeno injekcijsko brizgo Humire za injiciranje en alkoholni zloženec
2) Choosing and preparing an injection site
162 2) Izbira in priprava injekcijskega mesta
162 • Each new injection should be given at least 3 cm from the last injection site.
• Vsako naslednjo injekcijo morate dati vsaj 3 cm od mesta prejšnje injekcije.
• Do NOT shake the syringe. • Remove cap from needle syringe, being careful not to touch the needle or let it touch any surface. • With one hand, gently grasp the cleaned areas of skin and hold firmly
• Brizge NE STRESAJTE. • Odstranite pokrovček z igle na brizgi; pazite, da se igle pri tem ne dotaknete in da se z njo česa ne dotaknete. • Z eno roko obzirno primite očiščeni predel kože in ga trdno držite.
• With the other hand, hold syringe at 45-degree angle to skin, with the grooved side up. • With one quick, short motion, push needle all the way into skin • Release the skin with the first hand • Push plunger to inject solution – it can take from 2 to 5 seconds to empty the syringe • When the syringe is empty, remove the needle from skin, being careful to keep it at the same angle as when it was inserted • Using your thumb or a piece of gauze, apply pressure over the injection site for 10 seconds.
Pri tem pazite, da jo boste držali pod enakim kotom, pod katerim ste jo zabodli. • S palcem ali koščkom gaze 10 sekund pritiskajte na injekcijsko mesto.
• The Humira syringe should NEVER be reused.
NIKDAR ne nameščajte pokrovčka nazaj na iglo.
NEVER recap a needle. • After injecting Humira, immediately throw away the used syringe in a special container as instructed by your doctor, nurse or pharmacist. • Keep this container out of the reach and sight of children
163 • Po injiciranju Humire porabljeno brizgo takoj zavrzite v poseben vsebnik, kot vam je naročil zdravnik, medicinska sestra ali farmacevt. • Ta vsebnik shranjujte nedosegljivo otrokom.
Tell your doctor immediately if you notice any of the following: • Severe rash, hives or other signs of allergic reaction; • Swollen face, hands, feet; • Trouble breathing, swallowing; • Shortness of breath with exertion or upon lying down or swelling of the feet; • Signs and symptoms suggestive of blood disorders such as persistent fever, bruising, bleeding, paleness.
Svojemu zdravniku takoj povejte, če opazite kaj od naslednjega: • hud izpuščaj, koprivnico ali druge znake alergijske reakcije; • oteklost obraza, dlani in stopal; • težave pri dihanju, požiranju; • težko dihanje ob naporu ali med ležanjem ali otekanje nog; • znaki in simptomi, ki nakazujejo bolezni krvi, npr. trdovratna zvišana telesna temperatura, modrice, krvavitve, bledica.
Tell your doctor as soon as possible if you notice any of the following: • Signs of infection such as fever, feeling sick, wounds, dental problems, burning on urination; • Feeling weak or tired; • Coughing; • Tingling; • Numbness; • Double vision; • Arm or leg weakness; • A bump or open sore that does n't heal.
Zdravniku čim prej povejte, če opazite kaj od naslednjega: • znake okužbe, npr. zvišano telesno temperaturo, splošno slabo počutje, rane, težave z zobmi, pekoč občutek med uriniranjem; • občutek šibkosti ali utrujenosti; • kašelj; • mravljinčenje; • omrtvelost; • dvojni vid: • šibkost rok ali nog; • bula ali odprta rana, ki se ne zaceli.
Very common (inmore than 1 in 10 patients): • injection site reactions (including pain, swelling, redness or itching).
Zelo pogosto (pri več kot 1 od 10 bolnikov): • reakcije na mestu injiciranja (vključno z bolečino, oteklostjo, pordelostjo in srbenjem).
Common (in more than 1 in 100 patients but less than 1 in 10 patients): • lower respiratory tract infections (such as bronchitis, pneumonia); • upper respiratory tract infections (including cold, runny nose, sinus infection); • viral infections (including influenza, cold blisters and shingles) • bacterial infections (including urinary tract infection); • fungal infection; • dizziness, vertigo, headache, sensation disorders; • cough, sore throat; • nausea, diarrhoea, abdominal pain, mouth inflammation and ulcers; • elevated liver enzymes; • rash, itching; • musculoskeletal pain; • fever fatigue.
Pogosto (pri več kot 1 od 100 bolnikov, vendar manj kot pri 1 od 10 bolnikov): • okužbe spodnjih dihal (npr. bronhitis, pljučnica); • okužbe zgornjih dihal (vključno s prehladom, izcedkom iz nosu, okužbo obnosnih votlin); • virusne okužbe (vključno z gripo, ocvirki in pasovcem); • bakterijske okužbe (vključno z okužbami sečil); • glivične okužbe; • omotica, vrtoglavica, glavobol, motnje zaznavanja;
Uncommon (in more than 1 in 1000 patients but less than 1 in 100 patients): • serious infections (including tuberculosis, histoplasmosis and sepsis [blood poisoning]), joint infection; • skin infections, skin warts, superficial fungal infections; • anaemia, low white blood cell and platelet counts lymphopaenia (low immune cell counts); • swelling of thelymph nodes; • systemic lupus erythematosus; • allergic reactions(including seasonal and medicines allergy); • increased lipid and uric acid values, appetite disorders; • anxiety, depression, feeling sleepy and difficulty sleeping, shaking; • taste disturbances;
164 • kašelj, vnetje žrela; • občutek siljenja na bruhanje, driska, bolečine v trebuhu, vnetje in razjede v ustih; • zvišanje jetrnih encimov; • izpuščaj, srbenje; • mišičnoskeletna bolečina; • povišana telesna temperatura, utrujenost.
164 • vision disturbances, eye inflammation or infection; • ear discomfort; • sensation of heart beatingirregularly, high blood pressure, flushing; • asthma, shortness of breath, hoarseness; • abdominal symptoms (such as vomiting, constipation), rectal bleeding; • skin disorders (such as psoriasis, eczema or infections), itchy rash, slow wound healing, bruising, hair loss; • muscle weakness; • urinary disturbances (such as blood in urine, increased urinary frequency); • increased menstrual bleeding; • flu-like symptoms, chest pain, swelling of the feet; • accidental injury, impaired healing.
Občasno (pri več kot 1 od 1000 bolnikov, vendar manj kot pri 1 od 100 bolnikov): • resne okužbe (vključno s tuberkulozo, histoplazmozo in sepso [zastrupitev krvi]), okužba sklepa; • okužbe kože, bradavice na koži, povrhnje glivične okužbe; • anemija, zmanjšanje števila belih krvnih celic in krvnih ploščic, limfopenija (zmanjšano število imunskih celic v krvi); • oteklost bezgavk; • sistemski lupus eritematosus; • alergijske reakcije (vključno s sezonskimi alergijami in alergijami na zdravila); • zvišani lipidi in sečna kislina, motnje apetita; • tesnobnost, depresija, zaspanost in težave s spanjem, tresenje; • motnje okusa; • motnje vida, vnetje ali okužba očesa; • neprijeten občutek v ušesu; • občutek neenakomernega bitja srca, visok krvni pritisk, zardevanje; • astma, hitra zadihanost, hripavost; • trebušni simptomi (npr. bruhanje, zaprtje), krvavitve v danko; • bolezni kože (npr. luskavica, ekcem ali okužbe), srbeč izpuščaj, počasno celjenje ran, podplutbe, izpadanje las in dlak; • mišična šibkost; • motnje na sečilih (npr. kri v urinu, pogostejše uriniranje); • močnejše menstruacijske krvavitve; • simptomi podobni gripi, bolečine v prsih, otekanje stopal; • naključna poškodba, slabše celjenje.
• Guillain-Barré syndrome (muscle weakness, abnormal sensations, tingling in the arms and upper body); • intestinal perforation; • hepatosplenic T-cell lymphoma.
165 • visok nivo kalcija v krvi, ki je ponavadi brez simptomov, vendar lahko povzroči bolečine v trebuhu, depresijo, slabost in ledvične kamne, nizek nivo kalcija v krvi, ki lahko povzroči mravljinčenje v prstih rok in nog ter mišične krče; • nenormalna razgradnja mišic, ki lahko povzroči težave z ledvicami; • otekost v zadnjem delu žrela, tekočina okrog pljuč, ki lahko povzroči kratko sapo, bolečina pri globokem vdihu; • vnetje trebušnega maščevja, ki povzroči boleče vozličke; • razširitev v steni večje arterije, zožitev srčne zaklopke, ki je po navadi brez simptomov, a lahko povzroči kratko sapo med telesno dejavnostjo, bolečine v prsih in omedlevico, vnetje in krvni strdek v veni, zamašitev žile, občutek hitrega bitja srca; • multipla skleroza, šibkost ali ohromelost mišic obraza; • Guillain- Barréjev sindrom (mišična oslabelost, nenormalna občutenja, ščemenje v rokah in zgornjem delu telesa); • predrtje črevesa; • jetrnovranični limfom celic T.
165 If any of the side effects get serious, if you have any unusual effects, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Če katerikoli neželen učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Do not use the Humira pre-filled syringe after the expiry date stated on the label/ blister/ carton after EXP:
Zdravila Humira ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki/ pretisnem omotu/ škatli za “ Uporabno do: ”.
Humira 40 mg solution for injection in pre-filled syringe is supplied as a sterile solution of 40 mg adalimumab dissolved in 0.8 ml solution.
Humira 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi je na voljo kot sterilna raztopina 40 mg adalimumaba, raztopljenega v 0, 8 ml raztopine.
Each pack contains 1, 2, 4 or 6 pre-filled syringes for patient use with 1, 2, 4 or 6 alcohol pads, respectively.
6 alkoholnimi zloženci.
Humira is also available as a vial or a pre-filled pen.
166 Humira je na voljo tudi v vialah in kot napolnjen injekcijski peresnik.
Abbott Biotechnology Deutschland GmbH Max-Planck-Ring 2 D - 65205 Wiesbaden Germany
Abbott Biotechnology Deutschland GmBH Max- Planck- Ring 2 D- 65205 Wiesbaden Nemčija
166 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
Eesti Abbott Laboratories Baltics Vienī bas 87h LV-1004 Rī ga Läti Tel: + 371 67605580
167 Eesti Österreich Abbott Laboratories Baltics Vienības 87h LV- 1004 Rīga Läti Tel: + 371 67605580
Latvija Abbott Laboratories Baltics Vienī bas 87h LV-1004 Rī ga Tel: + 371 67605580
168 Latvija Abbott Laboratories Baltics Vienības 87h LV- 1004 Rīga Tel: + 371 67605580
Lietuva Abbott Laboratories Baltics Vienī bas 87h LV-1004 Rī ga Latvija Tel: + 371 67605580
Lietuva Abbott LaboratoriesBaltics Vienības 87h LV- 1004 Rīga Latvija Tel: + 371 67605580
It may harm them, even if their symptoms are the same as yours. − If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Adalimumab binds to a specific protein (tumour necrosis factor or TNFα), which is present at increased levels in inflammatory diseases such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’ s disease and psoriasis.
Adalimumab se veže na specifično beljakovino (tumorje nekrotizirajoči faktor ali TNFα), ki je pri vnetnih boleznih, kakršne so revmatoidni artritis, poliartikularni juvenilni idiopatski artritis, psoriatični artritis, ankilozirajoči spondilitis, Crohnova bolezen in luskavica (psoriaza), prisoten v večji koncentraciji.
169 Polyarticular juvenile idiopathic arthritis is an inflammatory disease, affecting one or more joints, with diagnosis typically occurring in children under the age of 16 years.
Morda boste najprej dobili druga imunomodulirajoča
You may first be given other disease-modifying medicines, such as methotrexate.
170 zdravila, npr. metotreksat.
• If you are allergic (hypersensitive) to adalimumab or any of the other ingredients of Humira.
• če ste alergični na (preobčutlji za) adalimumab ali katerokoli sestavino zdravila Humira.
170 • You might get infections more easily while you are receiving Humira treatment These infections may be more serious and include tuberculosis, infections caused by viruses, fungi or bacteria, or other opportunistic infections and sepsis that may, in rare case, be life-threatening.
Te okužbe so lahko resne in vključujejo tuberkulozo, okužbe, ki jih povzročijo virusi, glive ali bakterije ali druge oportunistične okužbe in sepso, in so lahko v redkih primerih smrtno nevarne.
• If you have demyelinating disease such as multiple sclerosis, your doctor will decide if you should receive Humira
• Če imate demielizirajočo bolezen, kot je multipla skleroza, bo zdravnik presodil, ali lahko dobivate Humiro.
Your doctor will decide if you should receive Humira.
Ta bo presodil, ali lahko dobivate Humiro.
People with more serious rheumatoid arthritis that have had the disease for a long time may have a higher than average risk of getting lymphoma, which is a kind of cancer that affects the lymph system.
Pri bolnikih z resnejšim revmatoidnim artritisom, ki imajo bolezen že dolgo, obstaja povečana verjetnost, da zbolijo za limfomom, to je rakom limfatičnega sistema.
171 • There have been cases of cancers, other than lymphoma, have been reported in patients with a specific type of lung disease called Chronic Obstructive Pulmonary Disease (COPD) treated with another TNF blocker.
• Pri bolnikih s posebno boleznijo pljuč, t. i. kronično obstruktivno pljučno boleznijo (KOPB), zdravljenim z nekim drugim zaviralcem TNF, so bili primeri rakov, ki niso bili limfomi.
If you are a breast-feeding mother, advise you should stop breast-feeding during Humira treatment, and for at least 5 months after the last Humira treatment.
Če dojite, morate dojenje med zdravljenjem s Humiro prekiniti in ne smete dojiti vsaj še 5 mesecev po zadnjem odmerku Humire.
The usual dose regimen for Crohn’ s disease is 80 mg atWeek 0 and followed by 40 mg every other week starting at week 2.
Običajna shema odmerjanja pri Crohnovi bolezni je 80 mg 0. teden, čemur sledi 40 mg vsak drugi teden od 2. tedna naprej.
In cases where a more rapid response is required your doctor may prescribe a dose of 160 mg at Week 0 (as 4 injections in one day or 2 injections per day for two consecutive days), 80 mg (2 injections) at Week 2, and thereafter as 40 mg (1 injection) every other week.
Kadar je potreben hitrejši odziv, vam zdravnik lahko predpiše odmerek 160 mg 0. teden (v 4 injekcijah na en dan ali v 2 injekcijah dva dni zapored), 80 mg (2 injekciji) 173 2. teden in potem 40 mg (1 injekcija) vsak drugi teden.
The usual dose
Odvisno od vašega odziva lahko zdravnik poveča odmerek na 40 mg vsak drugi teden.
172 for adults with psoriasis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Običajno odmerjanje za odrasle z luskavico (psoriazo) je začetni odmerek 80 mg, ki mu sledi 40 mg čez en teden in nato 40 mg vsak drugi teden.
2) Choosing and preparing an injection site
174 2) Izbira in priprava injekcijskega mesta
• With the other hand, hold syringe at 45-degree angle to skin, with the grooved side up. • With one quick, short motion, push needle all the way into skin • Release the skin with the first hand • Push plunger to inject solution – it can take from 2 to 5 seconds to empty the syringe • When the syringe is empty, remove the needle from skin, being careful to keep it at the same angle as when it was inserted • Hold the syringe in one hand and with the other hand slide the outer protective shield over the exposed needle until it locks in place • Using your thumb or a piece of gauze, apply pressure over the injection site for 10 seconds.
Pri tem pazite, da jo boste držali pod enakim kotom, pod katerim ste jo zabodli. • Z eno roko držite brizgo, z drugo pa potegnite zunanji ščitnik čez razgaljeno iglo, dokler se ne zaskoči. • S palcem ali koščkom gaze 10 sekund pritiskajte na injekcijsko mesto.
4) Throwing away supplies
175 4) Kako zavreči ostanke
If you forget to give yourself an injection, you should inject the next dose of Humira as soon as you remember.
Če pozabite dati injekcijo, si morate naslednji odmerek Humire injicirati, čim se spomnite.